These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 11034947)
1. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Li D; Saldeen T; Romeo F; Mehta JL Circulation; 2000 Oct; 102(16):1970-6. PubMed ID: 11034947 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Li DY; Zhang YC; Philips MI; Sawamura T; Mehta JL Circ Res; 1999 May; 84(9):1043-9. PubMed ID: 10325241 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Li D; Mehta JL Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1116-22. PubMed ID: 10764682 [TBL] [Abstract][Full Text] [Related]
4. gamma-tocopherol decreases ox-LDL-mediated activation of nuclear factor-kappaB and apoptosis in human coronary artery endothelial cells. Li D; Saldeen T; Mehta JL Biochem Biophys Res Commun; 1999 May; 259(1):157-61. PubMed ID: 10334932 [TBL] [Abstract][Full Text] [Related]
5. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Li D; Mehta JL Circulation; 2000 Jun; 101(25):2889-95. PubMed ID: 10869259 [TBL] [Abstract][Full Text] [Related]
6. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Mehta JL; Hu B; Chen J; Li D Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2203-8. PubMed ID: 12958047 [TBL] [Abstract][Full Text] [Related]
7. Effects of alpha-tocopherol on ox-LDL-mediated degradation of IkappaB and apoptosis in cultured human coronary artery endothelial cells. Li D; Saldeen T; Mehta JL J Cardiovasc Pharmacol; 2000 Sep; 36(3):297-301. PubMed ID: 10975585 [TBL] [Abstract][Full Text] [Related]
8. Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA. Wang X; Khaidakov M; Ding Z; Mitra S; Lu J; Liu S; Mehta JL Exp Biol Med (Maywood); 2012 Dec; 237(12):1394-401. PubMed ID: 23354398 [TBL] [Abstract][Full Text] [Related]
9. Facilitative interaction between angiotensin II and oxidised LDL in cultured human coronary artery endothelial cells. Mehta JL; Dayuan Li J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S70-S76. PubMed ID: 28095226 [TBL] [Abstract][Full Text] [Related]
10. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells. Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059 [TBL] [Abstract][Full Text] [Related]
12. Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells. Li D; Singh RM; Liu L; Chen H; Singh BM; Kazzaz N; Mehta JL Cardiovasc Res; 2003 Jan; 57(1):238-43. PubMed ID: 12504834 [TBL] [Abstract][Full Text] [Related]
13. Identification of apoptosis-inducing factor in human coronary artery endothelial cells. Zhang W; Shokeen M; Li D; Mehta JL Biochem Biophys Res Commun; 2003 Jan; 301(1):147-51. PubMed ID: 12535654 [TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1. Kang BY; Mehta JL J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Ruiz-Ortega M; Lorenzo O; Rupérez M; König S; Wittig B; Egido J Circ Res; 2000 Jun; 86(12):1266-72. PubMed ID: 10864918 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Wolf G; Wenzel U; Burns KD; Harris RC; Stahl RA; Thaiss F Kidney Int; 2002 Jun; 61(6):1986-95. PubMed ID: 12028439 [TBL] [Abstract][Full Text] [Related]
17. Oxidized LDL through LOX-1 modulates LDL-receptor expression in human coronary artery endothelial cells. Hu B; Li D; Sawamura T; Mehta JL Biochem Biophys Res Commun; 2003 Aug; 307(4):1008-12. PubMed ID: 12878212 [TBL] [Abstract][Full Text] [Related]
18. EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells. Jiang JX; Zhang SJ; Liu YN; Lin XX; Sun YH; Shen HJ; Yan XF; Xie QM Eur J Pharmacol; 2014 Mar; 727():43-51. PubMed ID: 24486707 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Ruiz-Ortega M; Lorenzo O; Rupérez M; Suzuki Y; Egido J Nephrol Dial Transplant; 2001; 16 Suppl 1():27-33. PubMed ID: 11369817 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II via activation of type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cells. Li D; Chen H; Mehta JL Hypertension; 2001 Nov; 38(5):1062-7. PubMed ID: 11711498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]